Prescription drug · ANDA
ivermectin NDC 42806-017
Ivermectin 3 mg/1 · Tablet · Oral · EPIC PHARMA LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 42806-017-20 | 42806001720 | 20 TABLET in 1 BOTTLE (42806-017-20)Marketed from Dec 15, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- ivermectin
- Generic name (nonproprietary)
- ivermectin
- Active ingredients
- Ivermectin — 3 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- EPIC PHARMA LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 218805
- Marketing start
- Listing expires
- Identifiers
- Product ID 42806-017_536cb4ae-71a5-47aa-a71e-f16b75c378d8SPL ID 536cb4ae-71a5-47aa-a71e-f16b75c378d8SPL set ID c8005642-3bf0-41b9-8a53-8b933c68c073RxCUI 311207UNII 8883YP2R6DUPC 0342806017203
- Pharmacologic class
- Antiparasitic; Pediculicide
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N442806001720followed by a unit qualifier and the quantityPackage 42806-0017-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Ivermectin tablets are indicated for the treatment of the following infections: Strongyloidiasis of the intestinal tract. Ivermectin tablets are indicated for the treatment of intestinal (i.e., nondisseminated) strongyloidiasis due to the nematode parasite Strongyloides stercoralis . This indication is based on clinical studies of both comparative and open-label designs, in which 64-100% of infected patients were cured following a single 200-mcg/kg dose of ivermectin. (See CLINICAL PHARMACOLOGY, Clinical Studies ) Onchocerciasis. Ivermectin tablets are indicated for the treatment of onchocerciasis due to the nematode parasite Onchocerca volvulus . This indication is bas…
Excerpt only. Read the full label for complete information.